Year None202420232022202120202019201820172016 02-27-2024 Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results 02-26-2024 Pliant Therapeutics to Participate in Upcoming Investor Conferences 02-07-2024 Pliant Therapeutics to Participate in Upcoming Investor Events 02-04-2024 Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis 01-03-2024 Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3